United Therapeutics Corporation · NASDAQ:UTHR

Mahon Paul A sold 8,300 United Therapeutics Corporation shares (Form 4)

Traded Apr 2, 2026 · Filed Apr 2, 2026

On Apr 2, 2026, Mahon Paul A (EVP & GENERAL COUNSEL) sold 8,300 United Therapeutics Corporation shares at an average US$565.87 for US$4.7M under a trading plan, leaving 45,172 shares. Filed Apr 2, 2026 (Form 4).

Sold
8,300 shares
Price
US$565.87 average (US$560.30 to US$571.61)
Value
US$4.7M
Holding after
45,172 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP & GENERAL COUNSEL

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 2, 2026Common StockOption exercise8,300US$146.0353,472Direct
Apr 2, 2026Common StockSale514US$560.3052,958Direct
Apr 2, 2026Common StockSale351US$561.6952,607Direct
Apr 2, 2026Common StockSale774US$562.3451,833Direct
Apr 2, 2026Common StockSale371US$563.5851,462Direct
Apr 2, 2026Common StockSale1,115US$564.5550,347Direct
Apr 2, 2026Common StockSale543US$565.6649,804Direct
Apr 2, 2026Common StockSale1,629US$566.6648,175Direct
Apr 2, 2026Common StockSale1,403US$567.5546,772Direct
Apr 2, 2026Common StockSale690US$568.7946,082Direct
Apr 2, 2026Common StockSale710US$569.6145,372Direct
Apr 2, 2026Common StockSale200US$571.6145,172Direct

Source

View original at SEC

Related